Role of clinical judgement in offering adjuvant chemotherapy for Breast Cancer patients in conjunction with tumour profiling test - Oncotype Dx: a single breast unit experience

被引：0
|
作者：
Patnam, Varun [1 ]
Pushdary, Kamal [1 ]
Leaver, Nick [1 ]
机构：
[1] Whiston Hosp, Prescot, England
来源：
BRITISH JOURNAL OF SURGERY | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
WSP 17.6
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [41] How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer
    Boer, Katalin
    Kaposi, Ambrus
    Kocsis, Judit
    Horvath, Zsolt
    Madaras, Balazs
    Savolt, Akos
    Klement, Gyorgy Benjamin
    Rubovszky, Gabor
    CANCERS, 2024, 16 (17)
  • [42] The level of agreement among medical oncologists on adjuvant chemotherapy decision for breast cancer pre and post Oncotype DX result
    Alkushi, A.
    Omair, A.
    Abusanad, A.
    Masuadi, E.
    Alamri, G.
    Abdulhafiz, N.
    Mohamed, A.
    Abualkair, O.
    ANNALS OF ONCOLOGY, 2021, 32 : S45 - S45
  • [43] Evaluation of the role of pharmacy technicians in reviewing the eligibility for Oncotype DX genomic test and the impact of the test on treatment plans in breast cancer patients
    Cheng, Vian
    Markarian, Adeline
    de Lemos, Mario L.
    Schaff, Kimberly
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (05) : 1167 - 1173
  • [44] Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients
    Williams, Austin D.
    McGreevy, Christopher M.
    Tchou, Julia C.
    De La Cruz, Lucy M.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 3605 - 3611
  • [45] Impact of OncoType DX™ Recurrence Score and Tumor Size on Making Chemotherapy Decisions in Breast Cancer Patients
    Goodwin, M. C.
    Hughes, J. H.
    Diego, M.
    Frazier, T. G.
    CANCER RESEARCH, 2009, 69 (24) : 835S - 835S
  • [46] Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients
    Austin D. Williams
    Christopher M. McGreevy
    Julia C. Tchou
    Lucy M. De La Cruz
    Annals of Surgical Oncology, 2020, 27 : 3605 - 3611
  • [47] Utility of Oncotype Dx in Male Breast Cancer Patients and Impact on Chemotherapy Administration A Comparative Study with Female Patients
    McGreevy, Christopher M.
    Williams, Austin D.
    Tchou, Julia C.
    De la Cruz, Lucy M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S39 - S39
  • [48] Treatment pattern of early-stage premenopausal breast cancer patients with low Oncotype DX score: Single center experience
    Al Saheli, Zaid Ihab
    Ammari, Omar
    Albusoul, Linda
    Dabak, Vrushali S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] The Role of Oncotype DX(R) Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer
    Pardo, Jaime A.
    Fan, Betty
    Mele, Alessandra
    Serres, Stephanie
    Valero, Monica G.
    Emhoff, Isha
    Alapati, Amulya
    James, Ted A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1320 - 1325
  • [50] Impact of Oncotype DX Recurrence Score on Adjuvant Chemotherapy Use for Hormone Receptor Positive Breast Cancer and Correlation with Pathologic Features
    Arvisais-Anhalt, Simone
    Strickland, Amanda
    Zhu, Hong
    Xiaohan, Xu
    Sarode, Venetia
    LABORATORY INVESTIGATION, 2018, 98 : 45 - 46
12345